Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
A PSA blood test measures prostate-specific antigen, a protein made by prostate cells. The test is most often used to help screen for prostate cancer or to monitor prostate health over time, but a higher PSA result is not the same as a cancer diagnosis. PSA can rise because of prostate cancer, benign prostate enlargement, prostatitis, urinary procedures, ejaculation, cycling, and normal age-related prostate changes.
Quick take
- What it measures: The amount of prostate-specific antigen in blood, usually reported in nanograms per milliliter (ng/mL).
- Sample type: Blood drawn from a vein in the arm.
- Fasting: Usually not required.
- Best preparation: Ask your clinician whether to avoid ejaculation and vigorous cycling for about 48 hours before testing, and whether to postpone testing after a urinary infection, prostate infection, catheterization, cystoscopy, or prostate biopsy.
- Key limitation: PSA is prostate-specific, not cancer-specific. It helps estimate risk and decide whether follow-up testing is needed.
- Typical self-pay range: About $55–$75 through several national direct-order lab options when mandatory physician or service fees are included, though prices and availability change.
What is PSA?
PSA stands for prostate-specific antigen. It is a protein produced by cells in the prostate gland. Most PSA is released into semen, but a small amount normally circulates in the blood. A PSA blood test measures that blood level.
The prostate is a small gland below the bladder that surrounds the urethra. Because the gland tends to enlarge with age and can become inflamed or infected, PSA results often reflect more than one possible process. The National Cancer Institute notes that prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis can all raise PSA. This is why PSA is useful as a screening and monitoring tool, but not definitive on its own.
Why a PSA blood test is ordered
A PSA test may be ordered in several different situations:
- Screening: To look for possible signs of prostate cancer in someone without symptoms.
- Risk assessment: To help decide whether additional testing, such as a repeat PSA, free PSA, prostate MRI, or biopsy, should be considered.
- Monitoring known prostate conditions: To track PSA trends in people with BPH, prostatitis, or other prostate concerns.
- After prostate cancer treatment: To monitor for recurrence after surgery, radiation, or other treatment. In this setting, clinicians may use a more sensitive PSA test and a different interpretation framework.
For screening, major medical groups emphasize shared decision-making because PSA testing has potential benefits and harms. The U.S. Preventive Services Task Force recommends that men ages 55 to 69 make an individual decision about PSA-based screening after discussing benefits and harms with a clinician, and recommends against routine screening in men age 70 and older. The American Cancer Society recommends that people considering screening have a chance to make an informed decision, with discussions starting earlier for those at higher risk.
People at higher risk may need a screening conversation earlier than average-risk patients. Risk factors include older age, Black or African American ancestry, a father or brother with prostate cancer—especially if diagnosed before age 65—and certain inherited cancer-risk patterns in the family. Timing should be individualized, especially if you have urinary symptoms, a strong family history, or a prior abnormal PSA.
How to prepare for a PSA blood test
A PSA test is a standard blood draw. You usually do not need to fast, and the sample can often be collected at a physician’s office, hospital lab, Quest or Labcorp patient service center, or another outpatient laboratory.
Preparation matters because temporary PSA increases can lead to anxiety and unnecessary follow-up. Use this checklist before your test:
| Before the test | Why it matters |
|---|---|
| Avoid ejaculation for about 48 hours if your clinician recommends it. | Ejaculation may temporarily raise PSA in some people. |
| Avoid vigorous cycling, motorcycle riding, or intense perineal pressure for about 48 hours if possible. | Pressure or vigorous activity around the prostate may transiently affect PSA. |
| Tell your clinician about urinary symptoms, fever, pelvic pain, or recent prostatitis. | Infection or inflammation can raise PSA and may make the result hard to interpret. |
| Report recent prostate biopsy, cystoscopy, catheter placement, urinary retention, or prostate procedures. | Procedures and irritation of the prostate or urinary tract can elevate PSA for weeks. |
| List prostate medications, especially finasteride or dutasteride. | These medicines can lower PSA, so clinicians may interpret the result differently. |
| Try to use the same lab for repeat testing when practical. | Small method-to-method differences can matter when watching PSA trends. |
The MedlinePlus PSA test guide also advises discussing medicines and recent procedures before testing. If you are being tested to follow a previously abnormal PSA, ask whether the goal is a standard total PSA, free PSA with total PSA, or ultrasensitive PSA; these are not interchangeable.
How to understand PSA results
PSA is usually reported as ng/mL. There is no single number that definitively separates “normal” from “abnormal.” A low PSA does not guarantee the absence of prostate cancer, and a high PSA does not prove cancer is present.
Historically, a PSA above 4.0 ng/mL has often been considered a threshold for additional evaluation. However, clinicians may use lower thresholds in younger people and higher thresholds in older people, because PSA tends to increase with age. The National Cancer Institute explains that some clinicians use cutoffs such as 2.5 ng/mL for younger men or 5.0 ng/mL for older men, depending on context.
| PSA finding | Common interpretation | What to ask next |
|---|---|---|
| Low and stable | Often reassuring, especially if consistent with age and risk profile. | Ask when, or whether, repeat screening is appropriate. |
| Borderline or mildly elevated | May reflect BPH, inflammation, recent ejaculation or cycling, lab variation, or early cancer. | Ask whether to repeat PSA after avoiding temporary influences. |
| Clearly elevated | Higher PSA generally means higher probability of prostate cancer, but benign causes remain common. | Ask about repeat testing, free PSA, DRE, MRI, or urology referral. |
| Rising over time | A trend may be more informative than a single value, especially if the same lab method is used. | Ask how quickly PSA is changing and whether prostate size or MRI should be considered. |
| Very low after prostate removal | After prostatectomy, PSA is expected to be very low or undetectable; interpretation is specialized. | Ask your treating urologist or oncologist what threshold applies to your treatment history. |
PSA interpretation can also change if you take finasteride or dutasteride, medications used for BPH and hair loss. These drugs can lower PSA. Do not stop them on your own, but make sure the ordering clinician and lab report reviewer know you take them.
Types of PSA tests you may see
Most screening starts with total PSA. Other PSA-related tests may be used when the total PSA is borderline, when prior results are unclear, or when a clinician is deciding whether biopsy is needed.
| Test | What it means | When it may be used |
|---|---|---|
| Total PSA | The overall PSA level in blood. | Most common first-line PSA screening and monitoring test. |
| Free PSA and percent free PSA | Measures PSA not bound to blood proteins and compares it with total PSA. | May help refine risk when total PSA is in a borderline range. |
| PSA velocity | How fast PSA changes over time. | Used cautiously because short-term fluctuations can be misleading. |
| PSA density | PSA level adjusted for prostate volume, usually measured by imaging. | May help distinguish BPH-related PSA elevation from more concerning patterns. |
| Ultrasensitive PSA | Measures very low PSA values. | Most often used after prostate cancer treatment, especially after prostatectomy. |
If you are ordering a test yourself, be careful not to substitute an ultrasensitive PSA or a bundled hormone panel when your clinician specifically requested a standard total PSA. The correct test depends on the clinical question.
What happens if PSA is high?
A high PSA result should usually be interpreted in steps rather than as an emergency conclusion. The appropriate next step depends on the value, age, risk factors, symptoms, medication history, and prior PSA trend.
- Confirm the result. If you have no symptoms and PSA is unexpectedly elevated, a clinician may repeat the PSA after several weeks, especially if ejaculation, cycling, illness, urinary symptoms, or a recent procedure could have affected the result. The National Cancer Institute describes repeat PSA testing in 6 to 8 weeks as a common approach after an abnormal screening result.
- Look for benign explanations. BPH, prostatitis, urinary tract infection, recent instrumentation, and urinary retention can all raise PSA. Treating a confirmed infection and retesting later may be appropriate.
- Assess prostate cancer risk. Risk is based on more than PSA. Clinicians consider age, family history, ancestry, digital rectal exam findings, prior biopsy history, prostate volume, and PSA trend.
- Consider secondary tests. Depending on the case, a clinician may order free PSA, other blood or urine markers, or prostate MRI before deciding whether biopsy is needed.
- Discuss biopsy only when warranted. A prostate biopsy is the test that can diagnose cancer, but it is invasive and has risks. MRI-targeted approaches may help focus biopsy decisions in some patients.
One reason careful follow-up matters is that false positives are common. The National Cancer Institute reports that about 6%–7% of men have a false-positive PSA result in a given screening round, and only about one-quarter of men biopsied because of an elevated PSA are found to have prostate cancer. That does not mean an elevated PSA should be ignored; it means the next step should be thoughtful and individualized.
Benefits and limitations of PSA screening
The main potential benefit of PSA screening is earlier detection of prostate cancer before symptoms develop. Some prostate cancers are aggressive, and early detection can create more treatment options.
The main limitations are false positives, false negatives, overdiagnosis, and overtreatment. Some prostate cancers grow so slowly that they would never cause symptoms during a person’s lifetime. Finding those cancers can still lead to anxiety, repeated testing, biopsy, and sometimes treatment side effects. This is why many guidelines emphasize a screening conversation rather than automatic testing for everyone.
Screening decisions are especially preference-sensitive for people in their late 50s and 60s, for people with higher inherited risk, and for healthy adults over 70 who are trying to weigh guideline recommendations against personal risk. A practical question to ask your clinician is: “If this PSA is high, what follow-up steps would we realistically consider?” If the answer is that you would not pursue MRI, biopsy, or treatment because of age, health status, or personal preference, screening may have less value.
How much does a PSA blood test cost?
Cost depends on how the test is ordered. If a clinician orders PSA as part of preventive care or evaluation of symptoms, the bill may involve the lab test, office visit, and insurance rules. Medicare Part B covers a PSA blood test once every 12 months for eligible men over 50, and Medicare.gov states that patients pay nothing for the PSA blood test itself when coverage requirements are met, though provider assignment and related services can affect other charges.
For direct-to-consumer self-pay testing, the important number is the effective total cost: the advertised test price plus mandatory physician, service, or collection fees. Optional home draw fees should be counted separately because not everyone uses them.
| Ordering option | Listed PSA price | Mandatory fee shown | Effective self-pay total | Notes |
|---|---|---|---|---|
| Quest Health Prostate Screening (PSA) | $69 | $6 physician service fee | $75 | In-person Quest collection; page states patients must be 18+, male patients 18–100; collection not available in certain locations such as AZ, HI, and PR for this product. |
| Labcorp OnDemand PSA Prostate Cancer Screening Test | $69 | No separate mandatory fee shown on the product page | $69 | In-person Labcorp collection; page states ages 18–100 and results commonly 1–2 days after sample arrives at the lab. |
| Request A Test Prostate-Specific Antigen Test | $57 Quest / $59 Labcorp | $4 per-order service fee | $61 Quest / $63 Labcorp | Uses a national physician network for the required order; lab choice and availability depend on location. |
| Walk-In Lab Prostate-Specific Antigen (PSA) Serum Test | $49 | $6 per-order physician fee | $55 | Self-pay online order with blood draw at a participating lab; verify whether the product is standard total PSA or another PSA variant before purchase. |
This comparison treats mandatory order-related fees as part of the total price and does not rank providers by commission or advertising relationship. Prices, coupon availability, state restrictions, and lab networks can change, so verify the checkout total before purchase. If your clinician needs the result in your medical record, ask whether a self-ordered result can be accepted or whether the clinician prefers to place the order directly.
When to contact a clinician promptly
PSA testing is not a substitute for medical care when symptoms are present. Contact a healthcare professional promptly if you have blood in urine or semen, new bone pain, unexplained weight loss, fever with urinary symptoms, inability to urinate, severe pelvic pain, or painful urination. These symptoms do not necessarily mean cancer, but they should not be managed with a screening test alone.
FAQs about the PSA blood test
What does a PSA blood test measure?
It measures prostate-specific antigen in the blood. PSA is made by prostate cells. Higher levels can occur with prostate cancer, but also with benign prostate enlargement, inflammation, infection, recent procedures, ejaculation, and some physical activities.
Do I need to fast before a PSA blood test?
Usually no. Fasting is not required for a standard PSA blood test unless it is being drawn with other tests that require fasting, such as certain glucose or lipid tests.
Should I avoid sex before a PSA test?
Many clinicians recommend avoiding ejaculation for about 48 hours before PSA testing because it can temporarily raise PSA in some people. If you did ejaculate shortly before an unexpectedly high test, tell your clinician before making decisions based on the result.
Can cycling affect PSA?
Vigorous cycling or pressure on the area near the prostate may transiently affect PSA. If you are trying to get the cleanest baseline result, ask whether to avoid cycling, motorcycle riding, or similar activities for about 48 hours before the blood draw.
What PSA level means cancer?
No PSA level by itself means cancer. Higher PSA levels generally raise concern, but diagnosis requires further evaluation and, when appropriate, biopsy. Some people with prostate cancer have PSA below traditional cutoffs, and many people with elevated PSA do not have cancer.
What is a normal PSA by age?
There is no universally accepted age-based normal range. PSA tends to rise with age, and some clinicians use age-adjusted thresholds. The lab report reference range is only a starting point; your prior results and risk factors matter.
What is free PSA?
Free PSA is the portion of PSA circulating unbound to blood proteins. Percent free PSA can sometimes help refine risk when total PSA is borderline, but it should be interpreted by a clinician in context.
How long do PSA results take?
Many outpatient labs report PSA within 1–3 business days, though timing varies by laboratory, collection site, day of week, and whether clinician review is required before release.
Can women or people without a prostate have PSA?
PSA testing is primarily used for people with a prostate. After prostate removal, very low or undetectable PSA may be monitored for recurrence. People assigned female at birth generally do not use PSA screening in the same way; any unusual PSA-related question should be handled by a clinician.
Is a PSA test covered by insurance?
Coverage depends on your plan, age, risk factors, diagnosis code, and whether the test is considered screening or diagnostic. Medicare covers a PSA blood test once every 12 months for eligible men over 50. Commercial insurance rules vary, and office visit charges may still apply.
Sources
- National Cancer Institute: Prostate-Specific Antigen (PSA) Test
- MedlinePlus: Prostate-Specific Antigen (PSA) Test
- U.S. Preventive Services Task Force: Prostate Cancer Screening Recommendation
- American Cancer Society: Prostate Cancer Early Detection Recommendations
- American Urological Association/Society of Urologic Oncology: Early Detection of Prostate Cancer Guideline
- Medicare.gov: Prostate Cancer Screenings
- Quest Health: Prostate Screening (PSA)
- Labcorp OnDemand: PSA Prostate Cancer Screening Test
- Request A Test: Prostate-Specific Antigen Test
- Walk-In Lab: Prostate-Specific Antigen (PSA) Serum Test
